(Q28577666)

Gene Ontology release 2020-05-02

Gene Ontology ID

GO:1990776

cellular response to angiotensin

1 reference

Gene Ontology release 2020-05-02

1 reference

Minjie Tian

1

1 reference

31 January 2017

Donglin Zhu

series ordinal

2

1 reference

31 January 2017

Wei Xie

series ordinal

3

1 reference

31 January 2017

Jingping Shi

series ordinal

4

1 reference

31 January 2017

language of work or name

English

0 references

publication date

19 October 2012

1 reference

31 January 2017

1 reference

31 January 2017

586

1 reference

31 January 2017

20

1 reference

31 January 2017

3737–3745

1 reference

31 January 2017

Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

The vascular hypothesis of Alzheimer's disease: bench to bedside and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

What Is an Angiotensin Converting Enzyme Inhibitor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

Angiotensins in Alzheimer's disease - friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

Angiotensins and Alzheimer's disease: a bench to bedside overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

Angiotensin II AT1 receptor blockade abolishes brain microvascular inflammation and heat shock protein responses in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

Blockade of AT1 receptors protects the blood-brain barrier and improves cognition in Dahl salt-sensitive hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to peroxisome proliferator-activated receptor-gamma activation in mice with chronic cerebral hypoperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

Central angiotensin II stimulation promotes β amyloid production in Sprague Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

Amyloid-β associated volume loss occurs only in the presence of phospho-tau

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

Effect of intracerebroventricular angiotensin II on body weight and food intake in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

Vascular risk factor detection and control may prevent Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

The influence of chronic cerebral hypoperfusion on cognitive function and amyloid β metabolism in APP overexpressing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

The brain RAS and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

Brain and peripheral angiotensin II play a major role in stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

Post-translational modifications of tau protein: implications for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

The GSK3 hypothesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

The role of GSK3 in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

Curcumin activates Wnt/β-catenin signaling pathway through inhibiting the activity of GSK-3β in APPswe transfected SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

Amyloid-β peptide alteration of tau exon-10 splicing via the GSK3β-SC35 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

Angiotensin AT1 receptor signalling pathways in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004

GSK-3α/β kinases and amyloid production in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.09.004